Stephen J. Kanes, MD, PhD, is affiliated with Sage Therapeutics, Inc, Cambridge, Massachusetts. Kanes has published research focused on major depressive disorder and its treatment, specifically examining the drug zuranolone. His work includes clinical trials assessing zuranolone's effects on depression and related symptoms such as anxiety and insomnia in women with postpartum depression. Kanes has collaborated with co-authors including Robert Lasser and Anita H. Clayton.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
